array:23 [
  "pii" => "S1578219015000608"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.03.010"
  "estado" => "S300"
  "fechaPublicacion" => "2015-05-01"
  "aid" => "1060"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2015;106:326-7"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1080
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 603
      "PDF" => 430
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:18 [
      "pii" => "S0001731014004190"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2014.05.010"
      "estado" => "S300"
      "fechaPublicacion" => "2015-05-01"
      "aid" => "1060"
      "copyright" => "Elsevier España, S.L.U. y AEDV"
      "documento" => "simple-article"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2015;106:326-7"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 866
        "formatos" => array:3 [
          "EPUB" => 4
          "HTML" => 542
          "PDF" => 320
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fico-cl&#237;nica</span>"
        "titulo" => "Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "326"
            "paginaFinal" => "327"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient With Severe Psoriasis Receiving Ustekinumab"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "J&#46; Gonz&#225;lez-Ramos, M&#46;L&#46; Alonso-Pacheco, A&#46; Mayor-Ibarguren, P&#46; Herranz-Pinto"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Gonz&#225;lez-Ramos"
              ]
              1 => array:2 [
                "nombre" => "M&#46;L&#46;"
                "apellidos" => "Alonso-Pacheco"
              ]
              2 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Mayor-Ibarguren"
              ]
              3 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Herranz-Pinto"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015000608"
          "doi" => "10.1016/j.adengl.2015.03.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000608?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004190?idApp=UINPBA000044"
      "url" => "/00017310/0000010600000004/v2_201505051016/S0001731014004190/v2_201505051016/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S157821901500061X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.03.011"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "1065"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:327-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1153
      "formatos" => array:3 [
        "EPUB" => 51
        "HTML" => 829
        "PDF" => 273
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Phrynoderma After Biliopancreatic Diversion"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "327"
          "paginaFinal" => "329"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Frinoderma asociado a derivaci&#243;n biliopancre&#225;tica"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 598
              "Ancho" => 1600
              "Tamanyo" => 180795
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#44; Violaceous&#44; suppurating papular and tuberose lesions&#44; some with scabs&#46; B&#44; Resolution of the phrynoderma lesions&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Abad, T&#46; Omiste, J&#46; Vera, Y&#46; Gilaberte"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Abad"
            ]
            1 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Omiste"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Vera"
            ]
            3 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Gilaberte"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731014004499"
        "doi" => "10.1016/j.ad.2014.08.009"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004499?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901500061X?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000004/v2_201505051007/S157821901500061X/v2_201505051007/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1578219015000876"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2014.10.006"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "1079"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:324-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 924
      "formatos" => array:3 [
        "EPUB" => 43
        "HTML" => 614
        "PDF" => 267
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Assessment of the Allergeaze<span class="elsevierStyleSup">&#174;</span> Patch Test Compared to Other Conventional Allergens"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "324"
          "paginaFinal" => "325"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Valoraci&#243;n del test allergeaze<span class="elsevierStyleSup">&#174;</span> versus otros alergenos convencionales"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Serra-Baldrich, L&#46;C&#46; S&#225;ez-Mart&#237;n, R&#46;M&#46; Su&#225;rez-Fern&#225;ndez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Serra-Baldrich"
            ]
            1 => array:2 [
              "nombre" => "L&#46;C&#46;"
              "apellidos" => "S&#225;ez-Mart&#237;n"
            ]
            2 => array:2 [
              "nombre" => "R&#46;M&#46;"
              "apellidos" => "Su&#225;rez-Fern&#225;ndez"
            ]
            3 => array:1 [
              "colaborador" => "Members of the Spanish Research Group on Dermatitis&#44; Cutaneous Allergy &#91;Grupo Espa&#241;ol de Investigaci&#243;n en Dermatitis y Alergia Cut&#225;nea&#93; &#40;GEIDAC&#41;"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0001731014004633"
        "doi" => "10.1016/j.ad.2014.10.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004633?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000876?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000004/v2_201505051007/S1578219015000876/v2_201505051007/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research letter</span>"
    "titulo" => "Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient With Severe Psoriasis Receiving Ustekinumab"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">To the Editor&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "326"
        "paginaFinal" => "327"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "J&#46; Gonz&#225;lez-Ramos, M&#46;L&#46; Alonso-Pacheco, A&#46; Mayor-Ibarguren, P&#46; Herranz-Pinto"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "J&#46;"
            "apellidos" => "Gonz&#225;lez-Ramos"
            "email" => array:1 [
              0 => "gnzalezramosjessica&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "M&#46;L&#46;"
            "apellidos" => "Alonso-Pacheco"
          ]
          2 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Mayor-Ibarguren"
          ]
          3 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Herranz-Pinto"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario La Paz&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Ustekinumab is a human monoclonal antibody directed against interleukins &#40;IL&#41; 12 and 23&#44; which are involved in the control of infections and tumors and the pathogenesis of psoriasis&#46; Animal model studies have shown that inhibition of IL-12 and IL-23 might promote carcinogenesis&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Biologic therapies are considered to be both safe and well tolerated&#44; but there is concern about their carcinogenic potential&#46; There have been several reports of lymphoproliferative disorders developing in patients under treatment with tumor necrosis factor &#40;TNF&#41; inhibitors&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#8211;4</span></a> We present the case of a 68-year-old man with a history of hypertension&#44; type 2 diabetes mellitus&#44; hypertriglyceridemia&#44; overweight&#44; and ischemic heart disease diagnosed with plaque psoriasis 13 years earlier&#46; Given the severity of his psoriasis&#44; the patient was administered psoralen plus UV-A therapy and methotrexate 15<span class="elsevierStyleHsp" style=""></span>mg&#47;wk for a year&#59; the treatment showed moderate effectiveness&#44; and rapid recurrence was observed following discontinuation of treatment&#46; In May 2008&#44; the patient was started on concomitant efalizumab and methotrexate &#40;7&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;wk&#41; therapy&#44; which was continued with satisfactory results until efalizumab was withdrawn from the market in 2009&#46; In March 2010&#44; the patient experienced a relapse and was administered ustekinumab&#44; which achieved adequate control of his psoriasis&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">In November 2012&#44; the patient was seen at the emergency department of our hospital with complaints of melena and upper abdominal pain&#46; A gastroscopy revealed a gastric tumor with signs of malignancy&#46; The tumor&#44; however&#44; was studied and monitored at another hospital &#8220;resultando infructuoso el intento de recuperar las muestras histologicas&#8221;&#46; The results showed a dense infiltrate composed of atypical lymphocytes without identifiable clusters of nodes&#46; In the immunohistochemical study&#44; the cells were positive for CD20 and BCL2&#44; and negative for CD10&#44; CD30&#44; cyclin D1&#44; and CD5&#46; The use of appropriate histological stains did not identify <span class="elsevierStyleItalic">Helicobacter pylori</span> or other microorganisms&#46; A diagnosis of low-grade gastric mucosa-associated lymphoid tissue &#40;MALT&#41; lymphoma was established&#44; with no metastases identified by positron electron tomography&#47;computed tomography&#46; The patient underwent 19 sessions of radiation therapy&#44; which resulted in complete remission according to a report dated April 2013&#44; which is when he came for a follow-up visit at our hospital&#46; On examination of this and other reports on the tumor&#44; it was decided to discontinue treatment with ustekinumab&#46; The patient&#39;s psoriasis&#44; however&#44; was kept under control with topical treatment&#44; which resulted in almost complete whitening of the lesions&#46; Nevertheless&#44; in August 2013&#44; the patient died suddenly of cerebral infarction&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The risk of malignancy in patients with psoriasis is a hotly debated topic&#46; Some authors have postulated that the risk might be higher than in the general population&#44; even in the absence of treatment&#44; due to the underlying chronic inflammation associated with psoriasis&#44; particularly in patients with comorbidities&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">There is also controversy surrounding the risk of lymphomas in patients with psoriasis&#46; It has been postulated that this potentially increased risk might be related to both the pathophysiology of psoriasis and the use of immunosuppressant therapy in this setting&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">There have been isolated reports of lymphomas developing in patients treated with a biologic&#44;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> and even of regression following withdrawal of the drug&#44; pointing to a possible causal relationship&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">The development of lymphomas in patients treated with ustekinumab is rare&#46; Data from landmark trials and a recent study of the safety of ustekinumab in psoriasis over a 5-year follow-up period showed that the risk of malignancy per 9000 patient-years was similar to that seen in the general population&#44; with just 1 patient presenting a possible Hodgkin lymphoma&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">In our review of the literature&#44; we found just 2 cases of MALT lymphoma that developed during infliximab therapy&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8&#44;9</span></a> Both patients had <span class="elsevierStyleItalic">H pylori</span> infection&#46; Lymphoma remission was observed in the 2 cases following interruption of the biologic and administration of <span class="elsevierStyleItalic">H&#160;pylori</span> eradication therapy &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The authors of both reports speculated that the TNF inhibitor might have acted by promoting <span class="elsevierStyleItalic">H pylori</span> infection and&#47;or by directly inducing the lymphoproliferative process&#46; They also did not rule out that previous immunosuppressant therapy or the patients&#8217; underlying diseases may have had a carcinogenic role&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">MALT lymphoma is a B-cell non-Hodgkin lymphoma&#46; It is usually low-grade and located in the gastrointestinal tract&#46; Ninety percent of patients with gastric MALT lymphoma have concomitant <span class="elsevierStyleItalic">H pylori</span> infection&#46; <span class="elsevierStyleItalic">H&#160;pylori</span> eradication therapy achieves remission in 80&#37; of low-grade lymphomas and in just 50&#37; of high-grade lymphomas&#46; This remission is maintained for many years following the eradication of infection&#46; Recurrence&#44; however&#44; is observed in 10&#37; of cases&#44; hence the need for lifetime endoscopic follow-up&#46; Radiation therapy is the next best option for patients who do not respond to eradication therapy&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">In conclusion&#44; we have presented the third case of a patient who developed gastric MALT lymphoma during biologic therapy and the first case involving a patient treated with ustekinumab&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8&#44;9</span></a> We cannot&#44; however&#44; rule out that the lymphoma may have been triggered by the patient&#39;s chronic inflammatory state induced by psoriasis&#44; or by previous use of immunosuppressant therapy&#46; It is&#44; of course&#44; also possible that the association was merely coincidential&#46; We stress the importance of treatment discontinuation in patients like ours who develop a lymphoma during biologic therapy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Gonz&#225;lez-Ramos J&#44; Alonso-Pacheco M&#44; Mayor-Ibarguren A&#44; Herranz-Pinto P&#46; Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab&#46; Actas Dermosifiliogr&#46; 2015&#59;106&#58;326&#8211;327&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; F&#44; female&#59; <span class="elsevierStyleItalic">Hp</span>&#44; <span class="elsevierStyleItalic">Helicobacter pylori&#59;</span> IS&#44; immunosuppressant&#59; M&#44; male&#59; PUVA&#44; psoralen plus UV-A therapy&#59; RA&#44; rheumatoid arthritis&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Reference&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex&#47;Age&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Previous IS Therapy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Current Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Latency&#44; mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">MALT Lymphoma&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Management&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Response&#44; mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Thonhofer et al&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">F&#47;64&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">RA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">MethotrexateSulfasalazine&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">InfliximabMethotrexate&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Paranasal sinus&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interruption of infliximab and methotrexateEradication <span class="elsevierStyleItalic">Hp</span> therapy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete&#44; 3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Girard et al&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#47;50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Psoriasis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PUVACiclosporinMethotrexateEtanerceptEfalizumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Infliximab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Stomach&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interruption of infliximabEradication <span class="elsevierStyleItalic">Hp</span> therapyMethotrexate &#40;psoriasis&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&#44; 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Current case&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#47;68&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Psoriasis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PUVAMethotrexateEfalizumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ustekinumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Stomach&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Radition therapyInterruption of ustekinumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete&#44; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab785726.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Mucosa-Associated Lymphoid Tissue &#40;MALT&#41; Lymphoma in Patients Receiving Biologic Therapy&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ustekinumab&#46; Neoplasias y otros aspectos de seguridad"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; Santos-Juanes"
                            1 => "P&#46; Coto"
                            2 => "GalacheF C&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "numero" => "Suppl 3"
                        "paginaInicial" => "39"
                        "paginaFinal" => "44"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis &#40;Part II of <span class="elsevierStyleSmallCaps">ii</span>&#41;&#58; Results from analyses of infections and malignancy from pooled phase <span class="elsevierStyleSmallCaps">ii</span> and <span class="elsevierStyleSmallCaps">ii</span> clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;B&#46; Gordon"
                            1 => "K&#46;A&#46; Papp"
                            2 => "R&#46;G&#46; Langley"
                            3 => "V&#46; Ho"
                            4 => "A&#46;B&#46; Kimball"
                            5 => "C&#46; Guzzo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2011.06.041"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2012"
                        "volumen" => "66"
                        "paginaInicial" => "742"
                        "paginaFinal" => "751"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21978572"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "TNF-alpha inhibitors&#58; Are they carcinogenic"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "G&#46; Raval"
                            1 => "P&#46; Mehta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2147/DHPS.S7829"
                      "Revista" => array:6 [
                        "tituloSerie" => "Drug Healthc Patient Saf"
                        "fecha" => "2010"
                        "volumen" => "2"
                        "paginaInicial" => "241"
                        "paginaFinal" => "247"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21701636"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tumor necrosis factor antagonist therapy and lymphoma development&#58; twenty-six cases reported to the Food and Drug Administration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;L&#46; Brown"
                            1 => "M&#46;H&#46; Greene"
                            2 => "S&#46;K&#46; Gershon"
                            3 => "E&#46;T&#46; Edwards"
                            4 => "M&#46;M&#46; Braun"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.10679"
                      "Revista" => array:7 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2002"
                        "volumen" => "46"
                        "paginaInicial" => "3151"
                        "paginaFinal" => "3158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12483718"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0213911111001683"
                          "estado" => "S300"
                          "issn" => "02139111"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Integrated approach to comorbidity in patients with psoriasis&#46; Working group on psoriasis-associated comorbidities"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Daud&#233;n"
                            1 => "S&#46; Casta&#241;eda"
                            2 => "C&#46; Su&#225;rez"
                            3 => "J&#46; Garc&#237;a-Campayo"
                            4 => "A&#46;J&#46; Blasco"
                            5 => "M&#46;D&#46; Aguilar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0001-7310(12)70001-7"
                      "Revista" => array:7 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "1"
                        "paginaFinal" => "64"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22364603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of lymphoma in patients with psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;M&#46; Gelfand"
                            1 => "D&#46;B&#46; Shin"
                            2 => "X&#46; Neimann Al Wang"
                            3 => "D&#46;J&#46; Margolis"
                            4 => "A&#46;B&#46; Troxel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.jid.5700410"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "2006"
                        "volumen" => "126"
                        "paginaInicial" => "2194"
                        "paginaFinal" => "2201"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16741509"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis&#58; Final results from 5 years of follow-up"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;A&#46; Papp"
                            1 => "C&#46;E&#46; Griffiths"
                            2 => "K&#46; Gordon"
                            3 => "M&#46; Lebwohl"
                            4 => "P&#46;O&#46; Szapary"
                            5 => "Y&#46; Wasfi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.12214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2013"
                        "volumen" => "168"
                        "paginaInicial" => "844"
                        "paginaFinal" => "854"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23301632"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46; Thonhofer"
                            1 => "M&#46; Gaugg"
                            2 => "M&#46; Kriessmayr"
                            3 => "H&#46;J&#46; Neumann"
                            4 => "L&#46; Erlacher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2004.026252"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2005"
                        "volumen" => "64"
                        "paginaInicial" => "1098"
                        "paginaFinal" => "1099"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15958773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastric MALT lymphoma in a patient receiving infliximab for psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Girard"
                            1 => "B&#46; Guillot"
                            2 => "D&#46; Bessis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2008.08664.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2008"
                        "volumen" => "159"
                        "paginaInicial" => "497"
                        "paginaFinal" => "498"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18547313"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Review article&#58; Common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46;P&#46; Gisbert"
                            1 => "X&#46; Calvet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Aliment PharmacolTher"
                        "fecha" => "2011"
                        "volumen" => "34"
                        "paginaInicial" => "1047"
                        "paginaFinal" => "1062"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010600000004/v2_201505051007/S1578219015000608/v2_201505051007/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010600000004/v2_201505051007/S1578219015000608/v2_201505051007/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000608?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Case and Research letter
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient With Severe Psoriasis Receiving Ustekinumab
Linfoma gástrico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab
J. González-Ramos
Corresponding author
gnzalezramosjessica@gmail.com

Corresponding author.
, M.L. Alonso-Pacheco, A. Mayor-Ibarguren, P. Herranz-Pinto
Servicio de Dermatología, Hospital Universitario La Paz, Madrid, Spain
Read
5187
Times
was read the article
2084
Total PDF
3103
Total HTML
Share statistics
 array:23 [
  "pii" => "S1578219015000608"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2015.03.010"
  "estado" => "S300"
  "fechaPublicacion" => "2015-05-01"
  "aid" => "1060"
  "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
  "copyrightAnyo" => "2014"
  "documento" => "simple-article"
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2015;106:326-7"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1080
    "formatos" => array:3 [
      "EPUB" => 47
      "HTML" => 603
      "PDF" => 430
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:18 [
      "pii" => "S0001731014004190"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2014.05.010"
      "estado" => "S300"
      "fechaPublicacion" => "2015-05-01"
      "aid" => "1060"
      "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; y AEDV"
      "documento" => "simple-article"
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2015;106:326-7"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 866
        "formatos" => array:3 [
          "EPUB" => 4
          "HTML" => 542
          "PDF" => 320
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Carta cient&#237;fico-cl&#237;nica</span>"
        "titulo" => "Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "326"
            "paginaFinal" => "327"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient With Severe Psoriasis Receiving Ustekinumab"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "J&#46; Gonz&#225;lez-Ramos, M&#46;L&#46; Alonso-Pacheco, A&#46; Mayor-Ibarguren, P&#46; Herranz-Pinto"
            "autores" => array:4 [
              0 => array:2 [
                "nombre" => "J&#46;"
                "apellidos" => "Gonz&#225;lez-Ramos"
              ]
              1 => array:2 [
                "nombre" => "M&#46;L&#46;"
                "apellidos" => "Alonso-Pacheco"
              ]
              2 => array:2 [
                "nombre" => "A&#46;"
                "apellidos" => "Mayor-Ibarguren"
              ]
              3 => array:2 [
                "nombre" => "P&#46;"
                "apellidos" => "Herranz-Pinto"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219015000608"
          "doi" => "10.1016/j.adengl.2015.03.010"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000608?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004190?idApp=UINPBA000044"
      "url" => "/00017310/0000010600000004/v2_201505051016/S0001731014004190/v2_201505051016/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S157821901500061X"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2015.03.011"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "1065"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:327-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1153
      "formatos" => array:3 [
        "EPUB" => 51
        "HTML" => 829
        "PDF" => 273
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Phrynoderma After Biliopancreatic Diversion"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "327"
          "paginaFinal" => "329"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Frinoderma asociado a derivaci&#243;n biliopancre&#225;tica"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 598
              "Ancho" => 1600
              "Tamanyo" => 180795
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A&#44; Violaceous&#44; suppurating papular and tuberose lesions&#44; some with scabs&#46; B&#44; Resolution of the phrynoderma lesions&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "L&#46; Abad, T&#46; Omiste, J&#46; Vera, Y&#46; Gilaberte"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Abad"
            ]
            1 => array:2 [
              "nombre" => "T&#46;"
              "apellidos" => "Omiste"
            ]
            2 => array:2 [
              "nombre" => "J&#46;"
              "apellidos" => "Vera"
            ]
            3 => array:2 [
              "nombre" => "Y&#46;"
              "apellidos" => "Gilaberte"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731014004499"
        "doi" => "10.1016/j.ad.2014.08.009"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004499?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157821901500061X?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000004/v2_201505051007/S157821901500061X/v2_201505051007/en/main.assets"
  ]
  "itemAnterior" => array:18 [
    "pii" => "S1578219015000876"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2014.10.006"
    "estado" => "S300"
    "fechaPublicacion" => "2015-05-01"
    "aid" => "1079"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2015;106:324-5"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 924
      "formatos" => array:3 [
        "EPUB" => 43
        "HTML" => 614
        "PDF" => 267
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case and Research Letter</span>"
      "titulo" => "Assessment of the Allergeaze<span class="elsevierStyleSup">&#174;</span> Patch Test Compared to Other Conventional Allergens"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "324"
          "paginaFinal" => "325"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Valoraci&#243;n del test allergeaze<span class="elsevierStyleSup">&#174;</span> versus otros alergenos convencionales"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "E&#46; Serra-Baldrich, L&#46;C&#46; S&#225;ez-Mart&#237;n, R&#46;M&#46; Su&#225;rez-Fern&#225;ndez"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "E&#46;"
              "apellidos" => "Serra-Baldrich"
            ]
            1 => array:2 [
              "nombre" => "L&#46;C&#46;"
              "apellidos" => "S&#225;ez-Mart&#237;n"
            ]
            2 => array:2 [
              "nombre" => "R&#46;M&#46;"
              "apellidos" => "Su&#225;rez-Fern&#225;ndez"
            ]
            3 => array:1 [
              "colaborador" => "Members of the Spanish Research Group on Dermatitis&#44; Cutaneous Allergy &#91;Grupo Espa&#241;ol de Investigaci&#243;n en Dermatitis y Alergia Cut&#225;nea&#93; &#40;GEIDAC&#41;"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0001731014004633"
        "doi" => "10.1016/j.ad.2014.10.008"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014004633?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000876?idApp=UINPBA000044"
    "url" => "/15782190/0000010600000004/v2_201505051007/S1578219015000876/v2_201505051007/en/main.assets"
  ]
  "en" => array:14 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case and Research letter</span>"
    "titulo" => "Gastric Mucosa-Associated Lymphoid Tissue Lymphoma in a Patient With Severe Psoriasis Receiving Ustekinumab"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">To the Editor&#58;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "326"
        "paginaFinal" => "327"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "J&#46; Gonz&#225;lez-Ramos, M&#46;L&#46; Alonso-Pacheco, A&#46; Mayor-Ibarguren, P&#46; Herranz-Pinto"
        "autores" => array:4 [
          0 => array:4 [
            "nombre" => "J&#46;"
            "apellidos" => "Gonz&#225;lez-Ramos"
            "email" => array:1 [
              0 => "gnzalezramosjessica&#64;gmail&#46;com"
            ]
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          1 => array:2 [
            "nombre" => "M&#46;L&#46;"
            "apellidos" => "Alonso-Pacheco"
          ]
          2 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Mayor-Ibarguren"
          ]
          3 => array:2 [
            "nombre" => "P&#46;"
            "apellidos" => "Herranz-Pinto"
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Servicio de Dermatolog&#237;a&#44; Hospital Universitario La Paz&#44; Madrid&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Ustekinumab is a human monoclonal antibody directed against interleukins &#40;IL&#41; 12 and 23&#44; which are involved in the control of infections and tumors and the pathogenesis of psoriasis&#46; Animal model studies have shown that inhibition of IL-12 and IL-23 might promote carcinogenesis&#46;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">Biologic therapies are considered to be both safe and well tolerated&#44; but there is concern about their carcinogenic potential&#46; There have been several reports of lymphoproliferative disorders developing in patients under treatment with tumor necrosis factor &#40;TNF&#41; inhibitors&#46;<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">2&#8211;4</span></a> We present the case of a 68-year-old man with a history of hypertension&#44; type 2 diabetes mellitus&#44; hypertriglyceridemia&#44; overweight&#44; and ischemic heart disease diagnosed with plaque psoriasis 13 years earlier&#46; Given the severity of his psoriasis&#44; the patient was administered psoralen plus UV-A therapy and methotrexate 15<span class="elsevierStyleHsp" style=""></span>mg&#47;wk for a year&#59; the treatment showed moderate effectiveness&#44; and rapid recurrence was observed following discontinuation of treatment&#46; In May 2008&#44; the patient was started on concomitant efalizumab and methotrexate &#40;7&#46;5<span class="elsevierStyleHsp" style=""></span>mg&#47;wk&#41; therapy&#44; which was continued with satisfactory results until efalizumab was withdrawn from the market in 2009&#46; In March 2010&#44; the patient experienced a relapse and was administered ustekinumab&#44; which achieved adequate control of his psoriasis&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">In November 2012&#44; the patient was seen at the emergency department of our hospital with complaints of melena and upper abdominal pain&#46; A gastroscopy revealed a gastric tumor with signs of malignancy&#46; The tumor&#44; however&#44; was studied and monitored at another hospital &#8220;resultando infructuoso el intento de recuperar las muestras histologicas&#8221;&#46; The results showed a dense infiltrate composed of atypical lymphocytes without identifiable clusters of nodes&#46; In the immunohistochemical study&#44; the cells were positive for CD20 and BCL2&#44; and negative for CD10&#44; CD30&#44; cyclin D1&#44; and CD5&#46; The use of appropriate histological stains did not identify <span class="elsevierStyleItalic">Helicobacter pylori</span> or other microorganisms&#46; A diagnosis of low-grade gastric mucosa-associated lymphoid tissue &#40;MALT&#41; lymphoma was established&#44; with no metastases identified by positron electron tomography&#47;computed tomography&#46; The patient underwent 19 sessions of radiation therapy&#44; which resulted in complete remission according to a report dated April 2013&#44; which is when he came for a follow-up visit at our hospital&#46; On examination of this and other reports on the tumor&#44; it was decided to discontinue treatment with ustekinumab&#46; The patient&#39;s psoriasis&#44; however&#44; was kept under control with topical treatment&#44; which resulted in almost complete whitening of the lesions&#46; Nevertheless&#44; in August 2013&#44; the patient died suddenly of cerebral infarction&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">The risk of malignancy in patients with psoriasis is a hotly debated topic&#46; Some authors have postulated that the risk might be higher than in the general population&#44; even in the absence of treatment&#44; due to the underlying chronic inflammation associated with psoriasis&#44; particularly in patients with comorbidities&#46;<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">5</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">There is also controversy surrounding the risk of lymphomas in patients with psoriasis&#46; It has been postulated that this potentially increased risk might be related to both the pathophysiology of psoriasis and the use of immunosuppressant therapy in this setting&#46;<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">6</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">There have been isolated reports of lymphomas developing in patients treated with a biologic&#44;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">3</span></a> and even of regression following withdrawal of the drug&#44; pointing to a possible causal relationship&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">4</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">The development of lymphomas in patients treated with ustekinumab is rare&#46; Data from landmark trials and a recent study of the safety of ustekinumab in psoriasis over a 5-year follow-up period showed that the risk of malignancy per 9000 patient-years was similar to that seen in the general population&#44; with just 1 patient presenting a possible Hodgkin lymphoma&#46;<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">7</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">In our review of the literature&#44; we found just 2 cases of MALT lymphoma that developed during infliximab therapy&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8&#44;9</span></a> Both patients had <span class="elsevierStyleItalic">H pylori</span> infection&#46; Lymphoma remission was observed in the 2 cases following interruption of the biologic and administration of <span class="elsevierStyleItalic">H&#160;pylori</span> eradication therapy &#40;<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>&#41;&#46; The authors of both reports speculated that the TNF inhibitor might have acted by promoting <span class="elsevierStyleItalic">H pylori</span> infection and&#47;or by directly inducing the lymphoproliferative process&#46; They also did not rule out that previous immunosuppressant therapy or the patients&#8217; underlying diseases may have had a carcinogenic role&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">MALT lymphoma is a B-cell non-Hodgkin lymphoma&#46; It is usually low-grade and located in the gastrointestinal tract&#46; Ninety percent of patients with gastric MALT lymphoma have concomitant <span class="elsevierStyleItalic">H pylori</span> infection&#46; <span class="elsevierStyleItalic">H&#160;pylori</span> eradication therapy achieves remission in 80&#37; of low-grade lymphomas and in just 50&#37; of high-grade lymphomas&#46; This remission is maintained for many years following the eradication of infection&#46; Recurrence&#44; however&#44; is observed in 10&#37; of cases&#44; hence the need for lifetime endoscopic follow-up&#46; Radiation therapy is the next best option for patients who do not respond to eradication therapy&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">10</span></a></p><p id="par0050" class="elsevierStylePara elsevierViewall">In conclusion&#44; we have presented the third case of a patient who developed gastric MALT lymphoma during biologic therapy and the first case involving a patient treated with ustekinumab&#46;<a class="elsevierStyleCrossRefs" href="#bib0090"><span class="elsevierStyleSup">8&#44;9</span></a> We cannot&#44; however&#44; rule out that the lymphoma may have been triggered by the patient&#39;s chronic inflammatory state induced by psoriasis&#44; or by previous use of immunosuppressant therapy&#46; It is&#44; of course&#44; also possible that the association was merely coincidential&#46; We stress the importance of treatment discontinuation in patients like ours who develop a lymphoma during biologic therapy&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Gonz&#225;lez-Ramos J&#44; Alonso-Pacheco M&#44; Mayor-Ibarguren A&#44; Herranz-Pinto P&#46; Linfoma g&#225;strico de tejido linfoide asociado a mucosa en un paciente con psoriasis grave en tratamiento con ustekinumab&#46; Actas Dermosifiliogr&#46; 2015&#59;106&#58;326&#8211;327&#46;</p>"
      ]
    ]
    "multimedia" => array:1 [
      0 => array:7 [
        "identificador" => "tbl0005"
        "etiqueta" => "Table 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Abbreviations&#58; F&#44; female&#59; <span class="elsevierStyleItalic">Hp</span>&#44; <span class="elsevierStyleItalic">Helicobacter pylori&#59;</span> IS&#44; immunosuppressant&#59; M&#44; male&#59; PUVA&#44; psoralen plus UV-A therapy&#59; RA&#44; rheumatoid arthritis&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Reference&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Sex&#47;Age&#44; y&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Disease&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Previous IS Therapy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Current Treatment&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Latency&#44; mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">MALT Lymphoma&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Management&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th><th class="td" title="table-head  " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Response&#44; mo&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Thonhofer et al&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">8</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">F&#47;64&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">RA&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">MethotrexateSulfasalazine&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">InfliximabMethotrexate&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">21&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Paranasal sinus&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interruption of infliximab and methotrexateEradication <span class="elsevierStyleItalic">Hp</span> therapy&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete&#44; 3&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Girard et al&#46;<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">9</span></a>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#47;50&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Psoriasis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PUVACiclosporinMethotrexateEtanerceptEfalizumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Infliximab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">13&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Stomach&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Interruption of infliximabEradication <span class="elsevierStyleItalic">Hp</span> therapyMethotrexate &#40;psoriasis&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Partial&#44; 1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry  " align="left" valign="top">Current case&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">M&#47;68&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Psoriasis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">PUVAMethotrexateEfalizumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Ustekinumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Stomach&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Radition therapyInterruption of ustekinumab&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="table-entry  " align="left" valign="top">Complete&#44; 4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab785726.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Mucosa-Associated Lymphoid Tissue &#40;MALT&#41; Lymphoma in Patients Receiving Biologic Therapy&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:10 [
            0 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Ustekinumab&#46; Neoplasias y otros aspectos de seguridad"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; Santos-Juanes"
                            1 => "P&#46; Coto"
                            2 => "GalacheF C&#46;"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "Actas Dermosifilogr"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "numero" => "Suppl 3"
                        "paginaInicial" => "39"
                        "paginaFinal" => "44"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis &#40;Part II of <span class="elsevierStyleSmallCaps">ii</span>&#41;&#58; Results from analyses of infections and malignancy from pooled phase <span class="elsevierStyleSmallCaps">ii</span> and <span class="elsevierStyleSmallCaps">ii</span> clinical trials"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;B&#46; Gordon"
                            1 => "K&#46;A&#46; Papp"
                            2 => "R&#46;G&#46; Langley"
                            3 => "V&#46; Ho"
                            4 => "A&#46;B&#46; Kimball"
                            5 => "C&#46; Guzzo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.jaad.2011.06.041"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Am Acad Dermatol"
                        "fecha" => "2012"
                        "volumen" => "66"
                        "paginaInicial" => "742"
                        "paginaFinal" => "751"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21978572"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "TNF-alpha inhibitors&#58; Are they carcinogenic"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "G&#46; Raval"
                            1 => "P&#46; Mehta"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2147/DHPS.S7829"
                      "Revista" => array:6 [
                        "tituloSerie" => "Drug Healthc Patient Saf"
                        "fecha" => "2010"
                        "volumen" => "2"
                        "paginaInicial" => "241"
                        "paginaFinal" => "247"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21701636"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Tumor necrosis factor antagonist therapy and lymphoma development&#58; twenty-six cases reported to the Food and Drug Administration"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;L&#46; Brown"
                            1 => "M&#46;H&#46; Greene"
                            2 => "S&#46;K&#46; Gershon"
                            3 => "E&#46;T&#46; Edwards"
                            4 => "M&#46;M&#46; Braun"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/art.10679"
                      "Revista" => array:7 [
                        "tituloSerie" => "Arthritis Rheum"
                        "fecha" => "2002"
                        "volumen" => "46"
                        "paginaInicial" => "3151"
                        "paginaFinal" => "3158"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12483718"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0213911111001683"
                          "estado" => "S300"
                          "issn" => "02139111"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Integrated approach to comorbidity in patients with psoriasis&#46; Working group on psoriasis-associated comorbidities"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "E&#46; Daud&#233;n"
                            1 => "S&#46; Casta&#241;eda"
                            2 => "C&#46; Su&#225;rez"
                            3 => "J&#46; Garc&#237;a-Campayo"
                            4 => "A&#46;J&#46; Blasco"
                            5 => "M&#46;D&#46; Aguilar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/S0001-7310(12)70001-7"
                      "Revista" => array:7 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2012"
                        "volumen" => "103"
                        "numero" => "Suppl 1"
                        "paginaInicial" => "1"
                        "paginaFinal" => "64"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22364603"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The risk of lymphoma in patients with psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J&#46;M&#46; Gelfand"
                            1 => "D&#46;B&#46; Shin"
                            2 => "X&#46; Neimann Al Wang"
                            3 => "D&#46;J&#46; Margolis"
                            4 => "A&#46;B&#46; Troxel"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/sj.jid.5700410"
                      "Revista" => array:6 [
                        "tituloSerie" => "J Invest Dermatol"
                        "fecha" => "2006"
                        "volumen" => "126"
                        "paginaInicial" => "2194"
                        "paginaFinal" => "2201"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16741509"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "7"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis&#58; Final results from 5 years of follow-up"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:6 [
                            0 => "K&#46;A&#46; Papp"
                            1 => "C&#46;E&#46; Griffiths"
                            2 => "K&#46; Gordon"
                            3 => "M&#46; Lebwohl"
                            4 => "P&#46;O&#46; Szapary"
                            5 => "Y&#46; Wasfi"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/bjd.12214"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2013"
                        "volumen" => "168"
                        "paginaInicial" => "844"
                        "paginaFinal" => "854"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23301632"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "8"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "R&#46; Thonhofer"
                            1 => "M&#46; Gaugg"
                            2 => "M&#46; Kriessmayr"
                            3 => "H&#46;J&#46; Neumann"
                            4 => "L&#46; Erlacher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1136/ard.2004.026252"
                      "Revista" => array:6 [
                        "tituloSerie" => "Ann Rheum Dis"
                        "fecha" => "2005"
                        "volumen" => "64"
                        "paginaInicial" => "1098"
                        "paginaFinal" => "1099"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15958773"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "9"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Gastric MALT lymphoma in a patient receiving infliximab for psoriasis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "C&#46; Girard"
                            1 => "B&#46; Guillot"
                            2 => "D&#46; Bessis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1365-2133.2008.08664.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Br J Dermatol"
                        "fecha" => "2008"
                        "volumen" => "159"
                        "paginaInicial" => "497"
                        "paginaFinal" => "498"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18547313"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "10"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Review article&#58; Common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "J&#46;P&#46; Gisbert"
                            1 => "X&#46; Calvet"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Aliment PharmacolTher"
                        "fecha" => "2011"
                        "volumen" => "34"
                        "paginaInicial" => "1047"
                        "paginaFinal" => "1062"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010600000004/v2_201505051007/S1578219015000608/v2_201505051007/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6157"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case and Research Letters"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010600000004/v2_201505051007/S1578219015000608/v2_201505051007/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219015000608?idApp=UINPBA000044"
]
Article information
ISSN: 15782190
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 6 7 13
2024 October 66 40 106
2024 September 94 29 123
2024 August 118 76 194
2024 July 78 41 119
2024 June 76 28 104
2024 May 65 34 99
2024 April 69 26 95
2024 March 77 29 106
2024 February 63 34 97
2024 January 52 30 82
2023 December 55 14 69
2023 November 60 26 86
2023 October 60 20 80
2023 September 69 31 100
2023 August 42 20 62
2023 July 58 40 98
2023 June 40 22 62
2023 May 37 22 59
2023 April 42 20 62
2023 March 49 17 66
2023 February 45 22 67
2023 January 45 37 82
2022 December 54 31 85
2022 November 24 34 58
2022 October 24 28 52
2022 September 17 45 62
2022 August 34 39 73
2022 July 19 33 52
2022 June 18 20 38
2022 May 30 34 64
2022 April 46 32 78
2022 March 49 51 100
2022 February 23 30 53
2022 January 38 36 74
2021 December 43 29 72
2021 November 42 46 88
2021 October 32 50 82
2021 September 38 33 71
2021 August 23 36 59
2021 July 29 28 57
2021 June 22 20 42
2021 May 19 15 34
2021 April 45 55 100
2021 March 44 20 64
2021 February 55 31 86
2021 January 28 20 48
2020 December 32 21 53
2020 November 31 23 54
2020 October 10 7 17
2020 September 33 5 38
2020 August 29 13 42
2020 July 21 14 35
2020 June 44 28 72
2020 May 34 29 63
2020 April 61 28 89
2020 March 37 20 57
2020 February 9 8 17
2020 January 4 12 16
2019 December 6 6 12
2019 November 4 2 6
2019 October 0 7 7
2019 September 0 6 6
2019 August 6 6 12
2019 July 4 8 12
2019 June 4 2 6
2019 May 5 9 14
2019 April 3 8 11
2019 March 2 8 10
2019 February 0 6 6
2019 January 6 1 7
2018 December 0 8 8
2018 October 4 0 4
2018 September 3 2 5
2018 August 0 25 25
2018 July 0 7 7
2018 June 0 3 3
2018 May 0 6 6
2018 April 0 3 3
2018 March 0 8 8
2018 February 14 6 20
2018 January 26 9 35
2017 December 33 6 39
2017 November 30 17 47
2017 October 25 12 37
2017 September 21 17 38
2017 August 17 9 26
2017 July 24 12 36
2017 June 36 17 53
2017 May 28 15 43
2017 April 18 24 42
2017 March 10 10 20
2017 February 16 24 40
2017 January 14 16 30
2016 December 47 16 63
2016 November 45 18 63
2016 October 29 11 40
2016 September 0 5 5
2016 August 0 8 8
2016 July 9 2 11
2016 June 13 3 16
2016 May 11 1 12
2016 April 12 1 13
2016 March 13 1 14
2016 February 9 3 12
2016 January 1 6 7
2015 December 10 0 10
2015 November 8 1 9
2015 October 1 1 2
2015 August 0 2 2
2015 July 10 1 11
2015 June 7 2 9
2015 May 12 8 20
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?